Dr. Roger Li is a genitourinary oncologist at Moffitt Cancer Center in Tampa, Florida. He completed advanced fellowship training at MD Anderson Cancer Center and has led multiple international clinical trials investigating novel therapeutics in urothelial malignancies.

Dr. Li’s translational research is focused on ctDNA and utDNA as actionable biomarkers, genomic characterization of genitourinary tumors, and the development of precision immunotherapy strategies. Dr. Li earned his medical degree from the University of California, Irvine.